Business
Opthea Doses First Patient in Ph2A for OPT-302 in Wet AMD
Opthea Doses First Patient in Ph2A for OPT-302 in Wet AMD

About this update from Opthea Limited
[{"type":"text","content":"Opthea Ltd has released a press release. View Attachment","length":222,"tagName":"div"}]